Literature DB >> 12638309

[Sphincter of Oddi dysfunction--prolonged medical therapy or early endoscopic sphincter ablation].

Ferenc Kovács1, Tibor Gyökeres, Gábor Elek, Akos Pap.   

Abstract

INTRODUCTION: Sphincter of Oddi dysfunction is a real challenge from both diagnostic and therapeutic point of view. PATIENTS AND METHODS: In the last two years the authors have performed ERCP and EST in 29 patients with positive evocative test results, who had important enzyme elevations and/or did not respond to prolonged medical treatment.
RESULTS: Endoscopic findings were positive in 25/29 patients (86.2%): 8 adenoma of p. Vateri, 17 papillitis were identified, and in 4 cases the papilla was intact. Histopathology obtained in 12 patients supported the diagnosis. In 6 patients, who underwent a postpapillotomy evocative test, after an average of 10 months follow up the results have been converted from positive to negative response in all but two cases. The two patients continued to have abdominal symptoms with persistent positive provocation tests because of restenosis, were treated with repapillotomy.
CONCLUSIONS: The Debray and Nardi tests are useful screening tests for hypertonic biliary or pancreatic dyskinesia. Structural endoscopic and histological findings are frequent already in the functional cases. Early sphincter ablation should be considered in failure of medical therapy for preventing the transformation of this functional disorder into an organic, potentially precancerous state.

Entities:  

Mesh:

Year:  2002        PMID: 12638309

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  2 in total

1.  Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy.

Authors:  Gábor Elek; Tibor Gyökeres; Eszter Schäfer; Mária Burai; Ferenc Pintér; Akos Pap
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

2.  Medical treatment for sphincter of oddi dysfunction: can it replace endoscopic sphincterotomy?

Authors:  Véronique Vitton; Salah Ezzedine; Jean-Michel Gonzalez; Mohamed Gasmi; Jean-Charles Grimaud; Marc Barthet
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.